Psychemedics Q3 revenue falls 9% to $5.2M; net loss narrows to $0.5M from $2.1M

PSYCHEMEDICS CORP

Q3 2024 revenue $5.2M, down 9% YoY from $5.7M; nine-month revenue $15.3M, down 11%.
Net loss narrowed to $0.5M ($0.09/share) vs $2.1M ($0.36/share) in prior-year Q3.
Nine-month net loss $2.1M ($0.35/share) vs $3.2M ($0.56/share) in 2023.

item 2.02 item 9.01

PSYCHEMEDICS CORP filing history →

Source: SEC EDGAR

accession 0001171843-24-006285

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.